Tag Archives: begins

Prince Charles’ charity begins partnership with Johnnie Walker over a unique Scottish dram

Charles, Camilla and the Queen herself were all in Scotland on Friday attending a multitude of royal engagements including a tree planting. The Prince of Wales, known as the Duke of Rothesay in Scotland, also had on his agenda the opening of Edinburgh’s new tourist attraction: Johnnie Walker Princes Street.

As a matter of fact, the whisky temple opened its doors a few weeks ago.

The building, which used to be the House of Fraser, represents an investment of £185m for Johnnie Walker’s parent company Diego.

Charles visited the 8-floor distillery-museum-school-rooftop bar complex before unveiling an official plaque on the 1820 terrace bar that has the privilege of a stunning view over Edinburg Castle and the city’s skyline.

His charity, The Prince’s Trust, is now set to work hand in hand with the Johnnie Walker Learning for Life Academy.

The company will deliver training and employment opportunities to support the recovery of hospitality and tourism across Scotland and the people who knock on The Prince’s Trust’s door in need of help.

The students of the said Walker Academy even prepared a special drink for Prince Charles.

Named after him, the “Duke of Rothesay” cocktail was made with Johnnie Walker Autumn (the first seasonal whisky exclusive to Johnnie Walker Princes Street) and garnished with ingredients from the gardens at Dumfries House estate.

In the Johnnie Walker Archive, His Royal Highness explored historical documents from the origins of Johnnie Walker and relating to the first granting of a Royal Warrant for the supply of its Scotch whiskies to the Royal Household by King George V in 1934.

READ MORE: Camilla praised for her involvement with cancer patients

Ivan Menezes, CEO of Diego, said: “It has been an honour to welcome His Royal Highness The Duke of Rothesay to officially open Johnnie Walker Princes Street and a pleasure to celebrate this special moment with our people and the students we are training for an exciting future in the hospitality industry.

“We are grateful to His Royal Highness for the interest he has shown in the Scotch whisky industry and we look forward to working in partnership with The Prince’s Foundation to create opportunities for people in communities across Scotland to get into training and employment in hospitality and tourism.”

Earlier in the day, the Prince of Wales joined his mother the Queen and schoolchildren from nearby Crathie Primary at Balmoral Castle to plant a tree.

As part of a special initiative marking her Platinum Jubilee, the tree represented the start of the planting season for a scheme called the Queen’s Green Canopy (QGC).

Kate’s ‘very tender’ moment with Charles sends message [PHOTOS] 
‘Beautiful’ Camilla dazzles in green dress and £5,000 earrings [INSIGHT] 
Camilla ‘held her own’ with Kate during the James Bond premiere [REPORT]

The project will encourage everyone to “plant a tree for the jubilee” between October and March.

“Let’s hope it will survive,” said Charles as he and his mother poured soil around the copper beech young tree.

Read more here Daily Express :: Royal Feed

EU regulator begins rolling review of Sanofi’s new coronavirus vaccine

France is back in the vaccine race after the European Medicines Agency announced today it would begin assessing early data supporting Sanofi’s coronavirus vaccine.

France’s hopes of developing a working vaccine were derailed at the end of 2020 when Sanofi announced its original vaccine candidate failed to produce a strong immune response in older people in early human trials. The news was a national humiliation and raised questions about the country’s standing in medical research.

Sanofi went back to the drawing board, however, and created a reworked vaccine, Vidprevtyn. The candidate is a recombinant protein based vaccine — similar to the technology used by Novavax — that uses an adjuvant from GlaxoSmithKline to boost people’s immune response.

The EMA has now begun a rolling review, which allows regulators to assess data as it comes in. Its assessment is based on promising lab studies and early human trials that “suggest that the vaccine triggers the production of antibodies” that target the coronavirus that causes COVID-19 “may help protect against the disease.”

Sanofi, in partnership with GSK, began Phase 3 human trials of its vaccine at the end of May. At the time, the companies predicted the vaccine could be approved by regulators in the fourth quarter of 2021.

The EMA, however, wouldn’t provide a timeline today for when it could make a decision. The company will still have to submit a formal conditional marketing authorization application.

The agency currently has four vaccines undergoing rolling reviews, including Novavax, Sputnik, Sinovac and CureVac.

The EU has a contract with the company that allows countries to buy up to 300 million doses of the vaccine.

Read more
This post originally posted here Coronavirus Search Results